Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orchard Therapeutics PLC (ORTX)
NASDAQ:ORTX
RESEARCH TOOLSreports
Orchard Therapeutics (ORTX) Stock Price & Analysis
1,688 Followers
ORTX Stock Chart & Stats
Day’s Range$16.63 - $16.72
52-Week Range― - ―
Previous Close$16.65
Volume372.35K
Average Volume (3M)N/A
Market Cap
$759.09M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Orchard Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ORTX FAQ
What was Orchard Therapeutics PLC’s price range in the past 12 months?
Currently, no data Available
What is Orchard Therapeutics PLC’s market cap?
Currently, no data Available
When is Orchard Therapeutics PLC’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Orchard Therapeutics PLC’s earnings last quarter?
Currently, no data Available
Is Orchard Therapeutics PLC overvalued?
According to Wall Street analysts Orchard Therapeutics PLC’s price is currently Overvalued.
Does Orchard Therapeutics PLC pay dividends?
Orchard Therapeutics PLC does not currently pay dividends.
What is Orchard Therapeutics PLC’s EPS estimate?
Orchard Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orchard Therapeutics PLC have?
Currently, no data Available
What happened to Orchard Therapeutics PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Orchard Therapeutics PLC?
Among the largest hedge funds holding Orchard Therapeutics PLC’s share is Deerfield Management Company, LP. It holds Orchard Therapeutics PLC’s shares valued at 2M.
---
Orchard Therapeutics Stock Smart Score
Company Description
Orchard Therapeutics PLC
Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.
---
ORTX Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ORTX
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+152.87%
reiterated a buy rating 10 months ago
Copying Hartaj Singh's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +152.87% per trade.
---